hotspot -WSS

hotspot

author：explore 2025-09-29 01:37:06 - browse：3

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Inequities make cancer less preventable for women: report

focus

WSS

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Sudafed saga points to U.S. issues with evaluating older drugs

Paxlovid should be available without a positive Covid test

Health AI adoption puts security, privacy startups on investors' radar

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Nurses recount patients attacks

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Address the ethical violations that led to 'Three Identical Strangers'

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inequities make cancer less preventable for women: report

Continuity nursing helped my family in our darkest PICU moments

Positive childhood experiences can help future health

In Memoriam: Notable people who died in 2023

Listen: Who gets the credit for GLP

United colonoscopy coverage change 'may cost lives,' doctors say

Future doctors should be trained to promote social change

knowledge

Neuroscience’s long legacy of racism

Shingles, which affected Dianne Feinstein, is on the rise

Biogen shutters digital health group, ends Apple study, in cost cutting move

Positive childhood experiences can help future health

Nurses recount patients attacks

WHO recommends dropping component of many flu vaccines

knowledge

hotspot

focus

focus